Saavedra, Belinda .
HRN: 02-97-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/05/2023
11/11/2023
IV
1.5g
Q12
CKD St V, CAP-MR, Rule Out Leptospirosis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes